Search Results

There are 13810 results for: content related to: PET IMAGING OF THE PHARMACOKINETICS OF SMALL MOLECULAR-WEIGHT DRUGS

  1. The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [11C]-raclopride and [11C]-(+)-PHNO PET

    Human Brain Mapping

    Fernando Caravaggio, Jun Ku Chung, Eric Plitman, Isabelle Boileau, Philip Gerretsen, Julia Kim, Yusuke Iwata, Raihaan Patel, M. Mallar Chakravarty, Gary Remington and Ariel Graff-Guerrero

    Version of Record online : 28 JUL 2017, DOI: 10.1002/hbm.23744

  2. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans

    Synapse

    Volume 64, Issue 6, June 2010, Pages: 478–485, Simon Cervenka, Andrea Varrone, Erik Fransén, Christer Halldin and Lars Farde

    Version of Record online : 19 FEB 2010, DOI: 10.1002/syn.20765

  3. The dopamine D1 receptor agonist (S)-[11C]N-methyl-NNC 01-0259 is not sensitive to changes in dopamine concentration—a positron emission tomography examination in the monkey brain

    Synapse

    Volume 67, Issue 9, September 2013, Pages: 586–595, S.J. Finnema, B. Bang-Andersen, M. Jørgensen, C.T. Christoffersen, B. Gulyás, H.V. Wikström, L. Farde and C. Halldin

    Version of Record online : 18 APR 2013, DOI: 10.1002/syn.21664

  4. PET and SPECT in Presurgical Evaluation of Epilepsy

    The Treatment of Epilepsy, Second Edition

    B. Sadzot, W. Van Paesschen, Pages: 652–664, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470752463.ch56

  5. Synthesis of [11C]Raclopride

    Radiochemical Syntheses: Radiopharmaceuticals for Positron Emission Tomography, Volume 1

    Peter J. H. Scott, Brian G. Hockley, Pages: 275–283, 2012

    Published Online : 4 JAN 2012, DOI: 10.1002/9781118140345.ch27

  6. You have free access to this content
    What have positron emission tomography and ‘Zippy’ told us about the neuropharmacology of drug addiction?

    British Journal of Pharmacology

    Volume 163, Issue 8, August 2011, Pages: 1586–1604, Paul Cumming, Daniele Caprioli and Jeffrey W Dalley

    Version of Record online : 25 JUL 2011, DOI: 10.1111/j.1476-5381.2010.01036.x

  7. Radiopharmaceuticals for assessing ABC transporters at the blood–brain barrier

    Clinical Pharmacology & Therapeutics

    Volume 97, Issue 4, April 2015, Pages: 362–371, RM Raaphorst, AD Windhorst, PH Elsinga, NA Colabufo, AA Lammertsma and G Luurtsema

    Version of Record online : 11 FEB 2015, DOI: 10.1002/cpt.73

  8. Positron emission tomography imaging of D2/3 agonist binding in healthy human subjects with the radiotracer [11C]-N-propyl-norapomorphine: Preliminary evaluation and reproducibility studies

    Synapse

    Volume 63, Issue 7, July 2009, Pages: 574–584, Rajesh Narendran, W. Gordon Frankle, N. Scott Mason, Charles M. Laymon, Brian J. Lopresti, Julie C. Price, Steve Kendro, Shivangi Vora, Maralee Litschge, James M. Mountz and Chester A. Mathis

    Version of Record online : 19 MAR 2009, DOI: 10.1002/syn.20633

  9. Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors

    Synapse

    Volume 63, Issue 6, June 2009, Pages: 462–475, Mette Skinbjerg, Yoon Namkung, Christer Halldin, Robert B. Innis and David R. Sibley

    Version of Record online : 13 FEB 2009, DOI: 10.1002/syn.20626

  10. [11C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET

    Synapse

    Volume 58, Issue 3, 1 December 2005, Pages: 173–183, Christer Halldin, Johan Lundberg, Judit Sóvágó, Balázs Gulyás, Denis Guilloteau, Johnny Vercouillie, Patrick Emond, Sylvie Chalon, Jari Tarkiainen, Jukka Hiltunen and Lars Farde

    Version of Record online : 1 SEP 2005, DOI: 10.1002/syn.20189

  11. Estimating the effect of endogenous dopamine on baseline [11C]-(+)-PHNO binding in the human brain

    Synapse

    Volume 70, Issue 11, November 2016, Pages: 453–460, Fernando Caravaggio, Lawrence S. Kegeles, Alan A. Wilson, Gary Remington, Carol Borlido, David C. Mamo and Ariel Graff-Guerrero

    Version of Record online : 11 JUL 2016, DOI: 10.1002/syn.21920

  12. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride

    Synapse

    Volume 63, Issue 6, June 2009, Pages: 447–461, Rajesh Narendran, W. Gordon Frankle, N. Scott Mason, Eugenii A. Rabiner, Roger N. Gunn, Graham E. Searle, Shivangi Vora, Maralee Litschge, Steve Kendro, Thomas B. Cooper, Chester A. Mathis and Marc Laruelle

    Version of Record online : 13 FEB 2009, DOI: 10.1002/syn.20628

  13. Pgp-Mediated Interaction Between (R)-[11C]Verapamil and Tariquidar at the Human Blood–Brain Barrier: A Comparison With Rat Data

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 2, February 2012, Pages: 227–233, M Bauer, M Zeitlinger, R Karch, P Matzneller, J Stanek, W Jäger, M Böhmdorfer, W Wadsak, M Mitterhauser, J P Bankstahl, W Löscher, M Koepp, C Kuntner, M Müller and Oliver Langer

    Version of Record online : 14 DEC 2011, DOI: 10.1038/clpt.2011.217

  14. Functional Neuroimaging of the Acute Effects of Drugs of Abuse

    Neuroimaging in Addiction

    Laurence John Reed, David J. Nutt, Pages: 83–104, 2011

    Published Online : 2 NOV 2011, DOI: 10.1002/9781119998938.ch4

  15. Positron emission tomography quantification of serotonin transporter binding in medication-free bipolar disorder

    Synapse

    Volume 70, Issue 1, January 2016, Pages: 24–32, Jeffrey M. Miller, Benjamin A. Everett, Maria A. Oquendo, R. Todd Ogden, J. John Mann and Ramin V. Parsey

    Version of Record online : 19 OCT 2015, DOI: 10.1002/syn.21868

  16. Synthesis of [11C]Flumazenil([11C]FMZ)

    Radiochemical Syntheses: Radiopharmaceuticals for Positron Emission Tomography, Volume 1

    Roberto Canales-Candela, Patrick J. Riss, Franklin I. Aigbirhio, Pages: 221–231, 2012

    Published Online : 4 JAN 2012, DOI: 10.1002/9781118140345.ch22

  17. You have full text access to this OnlineOpen article
    Using Positron Emission Tomography to Study Transporter-Mediated Drug–Drug Interactions in Tissues

    Clinical Pharmacology & Therapeutics

    Volume 96, Issue 2, August 2014, Pages: 206–213, B Wulkersdorfer, T Wanek, M Bauer, M Zeitlinger, M Müller and O Langer

    Version of Record online : 28 MAR 2014, DOI: 10.1038/clpt.2014.70

  18. Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: A PET study

    Synapse

    Volume 38, Issue 2, November 2000, Pages: 138–143, Yuan-Hwa Chou, Christer Halldin and Lars Farde

    Version of Record online : 18 SEP 2000, DOI: 10.1002/1098-2396(200011)38:2<138::AID-SYN4>3.0.CO;2-7

  19. Dysfunctional Brain Networks and Genetic Risk for Schizophrenia: Specific Neurotransmitter Systems

    CNS Neuroscience & Therapeutics

    Volume 17, Issue 2, April 2011, Pages: 89–96, Jussi Hirvonen and Jarmo Hietala

    Version of Record online : 28 DEC 2010, DOI: 10.1111/j.1755-5949.2010.00223.x

  20. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans

    Human Brain Mapping

    Volume 29, Issue 4, April 2008, Pages: 400–410, Ariel Graff-Guerrero, Matthaeus Willeit, Nathalie Ginovart, David Mamo, Romina Mizrahi, Pablo Rusjan, Irina Vitcu, Philip Seeman, Alan A. Wilson and Shitij Kapur

    Version of Record online : 11 MAY 2007, DOI: 10.1002/hbm.20392